Pricing changes for Canada’s patented medicines are on their way and stakeholders are anticipating the release of the updated guidelines. … Read More

PDCI presented a case study on the proposed amendments to the PMPRB regulations in Canada at the 2019 … Read More

Article by PDCI Market Access featured in TELUS Health Insights Magazine

Members of the PDCI Team recently published an article and … Read More

Private health plans in Canada continue to implement many changes in their design and use of technology aimed at balancing … Read More

In December 2017, the Governor-in-Council published in Canada Gazette Part 1 the most comprehensive changes affecting patented medicines since Bill … Read More

The release of the Patented Medicine Prices Review Board (PMPRB) Annual Report is delayed once again this year – so … Read More

Owing to new developments and growing stakeholder interest, PDCI and H3 have now completed a second private payer PLA survey. … Read More